CD8A and neoplasm: In fact, SCFA enhance the CD8+ cytotoxic activity and CAR T-cells by reducing histone deacetylases and increasing IL-12 responses, leading to the production of interferon-γ (IFNγ) and tumor necrosis factor (TNF), thus concurring in anti-tumor immunity [218,219].